Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: GALECTIN-3, . Treffer: 20
2021
Gülen, T; Teufelberger, A; Ekoff, M; Westerberg, CM; Lyberg, K; Dahlén, SE; Dahlén, B; Nilsson, G
Distinct plasma biomarkers confirm the diagnosis of mastocytosis and identify increased risk of anaphylaxis.
J Allergy Clin Immunol. 2021;
Doi: 10.1016/j.jaci.2021.02.023
Web of Science
PubMed
FullText
FullText_MUG
Hall, L; Guo, C; Tandy, S; Broadhouse, K; Dona, AC; Malle, E; Bartels, ED; Christoffersen, C; Grieve, SM; Figtree, G; Hawkins, CL; Davies, MJ
Oral pre-treatment with thiocyanate (SCN-) protects against myocardial ischaemia-reperfusion injury in rats.
Sci Rep. 2021; 11(1):12712
Doi: 10.1038/s41598-021-92142-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Salib, M; Girerd, S; Girerd, N; März, W; Scharnagl, H; Massy, ZA; Leroy, C; Duarte, K; Holdaas, H; Jardine, AG; Schmieder, RE; Fellström, B; López-Andrés, N; Rossignol, P; Zannad, F
Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial.
Clin Res Cardiol. 2021;
Doi: 10.1007/s00392-021-01898-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Grübler, MR; Delgado, G; Kleber, M; Hartaigh, BÓ; de, Boer, RA; Verheyen, N; Keppel, M; Schmid, J; Siontis, GC; Räber, L; Pieske, B; Pilz, S; Tomaschitz, A; März, W
Effect of Galectin 3 on Aldosterone-Associated Risk of Cardiovascular Mortality in Patients Undergoing Coronary Angiography.
Am J Cardiol. 2020; 127:9-15
Doi: 10.1016/j.amjcard.2020.04.017
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Santens, B; Van De Bruaene, A; De Meester, P; D'Alto, M; Reddy, S; Bernstein, D; Koestenberger, M; Hansmann, G; Budts, W
Diagnosis and treatment of right ventricular dysfunction in congenital heart disease.
Cardiovasc Diagn Ther. 2020; 10(5):1625-1645
Doi: 10.21037/cdt-20-370
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Strobl, J; Pandey, RV; Krausgruber, T; Bayer, N; Kleissl, L; Reininger, B; Vieyra-Garcia, P; Wolf, P; Jentus, MM; Mitterbauer, M; Wohlfarth, P; Rabitsch, W; Stingl, G; Bock, C; Stary, G
Long-term skin-resident memory T cells proliferate in situ and are involved in human graft-versus-host disease.
Sci Transl Med. 2020; 12(570):
Doi: 10.1126/scitranslmed.abb7028
Web of Science
PubMed
FullText
FullText_MUG
2019
Crnkovic, S; Egemnazarov, B; Damico, R; Marsh, LM; Nagy, BM; Douschan, P; Atsina, K; Kolb, TM; Mathai, SC; Hooper, JE; Ghanim, B; Klepetko, W; Fruhwald, F; Lassner, D; Olschewski, A; Olschewski, H; Hassoun, PM; Kwapiszewska, G
Disconnect between Fibrotic Response and Right Ventricular Dysfunction.
Am J Respir Crit Care Med. 2019; 199(12):1550-1560
Doi: 10.1164/rccm.201809-1737OC
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2018
Zelzer, S; Tatzber, F; Herrmann, M; Wonisch, W; Rinnerhofer, S; Kundi, M; Obermayer-Pietsch, B; Niedrist, T; Cvirn, G; Wultsch, G; Mangge, H
Work Intensity, Low-Grade Inflammation, and Oxidative Status: A Comparison between Office and Slaughterhouse Workers.
Oxid Med Cell Longev. 2018; 2018(7):2737563-2737563
Doi: 10.1155/2018/2737563
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Gleissner, CA; Erbel, C; Linden, F; Domschke, G; Akhavanpoor, M; Helmes, CM; Doesch, AO; Kleber, ME; Katus, HA; Maerz, W
Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: Insights from the LURIC study.
Atherosclerosis. 2017; 260(1):121-129
Doi: 10.1016/j.atherosclerosis.2017.03.031
Web of Science
PubMed
FullText
FullText_MUG
2016
Calvier, L; Legchenko, E; Grimm, L; Sallmon, H; Hatch, A; Plouffe, BD; Schroeder, C; Bauersachs, J; Murthy, SK; Hansmann, G
Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension.
Heart. 2016; 102(5):390-6
Doi: 10.1136/heartjnl-2015-308365
Web of Science
PubMed
FullText
FullText_MUG
Jansen, H; Koenig, W; Jaensch, A; Mons, U; Breitling, LP; Scharnagl, H; Stojakovic, T; Schunkert, H; Brenner, H; Rothenbacher, D
Prognostic Utility of Galectin-3 for Recurrent Cardiovascular Events During Long-term Follow-up in Patients with Stable Coronary Heart Disease: Results of the KAROLA Study.
Clin Chem. 2016; 62(10):1372-1379
Doi: 10.1373/clinchem.2016.257550
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mueller, T; Egger, M; Leitner, I; Gabriel, C; Haltmayer, M; Dieplinger, B
Reference values of galectin-3 and cardiac troponins derived from a single cohort of healthy blood donors.
Clin Chim Acta. 2016; 456(4):19-23
Doi: 10.1016/j.cca.2016.02.014
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Weilner, S; Keider, V; Winter, M; Harreither, E; Salzer, B; Weiss, F; Schraml, E; Messner, P; Pietschmann, P; Hildner, F; Gabriel, C; Redl, H; Grillari-Voglauer, R; Grillari, J
Vesicular Galectin-3 levels decrease with donor age and contribute to the reduced osteo-inductive potential of human plasma derived extracellular vesicles.
Aging (Albany NY). 2016; 8(1):16-33
Doi: 10.18632/aging.100865
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zile, MR; Jhund, PS; Baicu, CF; Claggett, BL; Pieske, B; Voors, AA; Prescott, MF; Shi, V; Lefkowitz, M; McMurray, JJ; Solomon, SD; Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction (PARAMOUNT) Investigators
Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.
Circ Heart Fail. 2016; 9(1):
Doi: 10.1161/CIRCHEARTFAILURE.115.002551
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Drechsler, C; Delgado, G; Wanner, C; Blouin, K; Pilz, S; Tomaschitz, A; Kleber, ME; Dressel, A; Willmes, C; Krane, V; Krämer, BK; März, W; Ritz, E; van Gilst, WH; van der Harst, P; de Boer, RA
Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies.
J Am Soc Nephrol. 2015; 26(9):2213-2221
Doi: 10.1681/ASN.2014010093
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Edelmann, F; Holzendorf, V; Wachter, R; Nolte, K; Schmidt, AG; Kraigher-Krainer, E; Duvinage, A; Unkelbach, I; Düngen, HD; Tschöpe, C; Herrmann-Lingen, C; Halle, M; Hasenfuss, G; Gelbrich, G; Stough, WG; Pieske, BM
Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial.
Eur J Heart Fail. 2015; 17(2):214-223
Doi: 10.1002/ejhf.203
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Dieplinger, B; Egger, M; Haltmayer, M; Kleber, ME; Scharnagl, H; Silbernagel, G; de Boer, RA; Maerz, W; Mueller, T
Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.
Clin Chem. 2014; 60(3):530-540
Doi: 10.1373/clinchem.2013.209858
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
de Boer, RA; Edelmann, F; Cohen-Solal, A; Mamas, MA; Maisel, A; Pieske, B
Galectin-3 in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2013; 15(10):1095-1101
Doi: 10.1093/eurjhf/hft077
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2011
Alge-Priglinger, CS; André, S; Schoeffl, H; Kampik, A; Strauss, RW; Kernt, M; Gabius, HJ; Priglinger, SG
Negative regulation of RPE cell attachment by carbohydrate-dependent cell surface binding of galectin-3 and inhibition of the ERK-MAPK pathway.
Biochimie. 2011; 93(3):477-488
Doi: 10.1016/j.biochi.2010.10.021
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2003
Feilchenfeldt, J; Tötsch, M; Sheu, SY; Robert, J; Spiliopoulos, A; Frilling, A; Schmid, KW; Meier, CA
Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry.
Mod Pathol. 2003; 16(11): 1117-1123.
Doi: 10.1097/01.MP.0000096047.99202.31
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG